Information for "The particular usefulness along with protection associated with SGLT2 inhibitors joined with ACEIARBs from the management of type 2 diabetes mellitus A new metaanalysis associated with randomized managed research"
From EECH Central
Basic information
| Display title | The particular usefulness along with protection associated with SGLT2 inhibitors joined with ACEIARBs from the management of type 2 diabetes mellitus A new metaanalysis associated with randomized managed research |
| Default sort key | The particular usefulness along with protection associated with SGLT2 inhibitors joined with ACEIARBs from the management of type 2 diabetes mellitus A new metaanalysis associated with randomized managed research |
| Page length (in bytes) | 3,528 |
| Page ID | 1440889 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Soundsarah49 (Talk | contribs) |
| Date of page creation | 14:03, 5 May 2024 |
| Latest editor | Soundsarah49 (Talk | contribs) |
| Date of latest edit | 14:03, 5 May 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
